Modulation of 17β‐Estradiol Signaling on Cellular Proliferation by Caveolin‐2
- 19 October 2015
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 231 (6) , 1219-1225
Abstract
The sex hormone 17β‐estradiol (E2) exerts pleiotropic effects by binding to the ligand‐activated transcription factor estrogen receptor α (ERα). The E2:ERα complex regulates several physiological processes, including cell survival and proliferation, through transcriptional effects (i.e., estrogen responsive element [ERE]‐based gene transcription) and non‐transcriptional membrane‐initiated effects (i.e., the activation of extra‐nuclear signaling cascades), which derive from the activation of the pool of ERα that is localized to plasma membrane caveolae. Caveolae are ω‐shaped membrane sub‐domains that are composed of scaffold proteins named caveolins (i.e., caveolin‐1, caveolin‐2, and caveolin‐3). Although caveolin‐3 is exclusively expressed in muscles, caveolin‐1 and caveolin‐2 are co‐expressed in all human tissues. From a functional point of view, caveolin‐2 can operate both dependently on and independently of caveolin‐1, which is the main coat component of caveolae. Interestingly, while a functional interplay between caveolin‐1 and ERα has been reported in the control of E2‐induced physiological effects, the role of caveolin‐2 in E2:ERα signaling within the cell remains poorly understood. This study shows that siRNA‐mediated caveolin‐2 depletion in breast ductal carcinoma cells (MCF‐7) reduces E2‐induced ERα phosphorylation at serine residue 118 (S118), controls intracellular receptor levels, precludes ERα‐mediated extra‐nuclear activation of signaling pathways, reduces ERα transcriptional activity, and prevents cellular proliferation. Meanwhile, the impact of caveolin‐1 depletion on ERα signaling in MCF‐7 cells is shown to be similar to that elicited by siRNA‐mediated caveolin‐2 depletion. Altogether, these data demonstrate that caveolin‐2 expression is necessary for the control of E2‐dependent cellular proliferation. J. Cell. Physiol. 231: 1219–1225, 2016.Keywords
Funding Information
- AIRC-Associazione Italiana Ricerca sul Cancro (MFAG12756)
This publication has 32 references indexed in Scilit:
- Caveolin-1-Enhanced Motility and Focal Adhesion Turnover Require Tyrosine-14 but Not Accumulation to the Rear in Metastatic Cancer CellsPLOS ONE, 2012
- DHHC-7 and -21 are palmitoylacyltransferases for sex steroid receptorsMolecular Biology of the Cell, 2012
- The Effects of 17β-estradiol in Cancer are Mediated by Estrogen Receptor Signaling at the Plasma MembraneFrontiers in Physiology, 2011
- A potential role for caveolin-1 in estradiol-17β-induced proliferation of mouse embryonic stem cells: Involvement of Src, PI3K/Akt, and MAPKs pathwaysThe International Journal of Biochemistry & Cell Biology, 2009
- Caveolin 1 and Caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotypeBritish Journal of Cancer, 2008
- An Inherent Role of Integrin-Linked Kinase-Estrogen Receptor α Interaction in Cell MigrationCancer Research, 2006
- Estrogen Receptor-α Phosphorylated at Ser118 Is Present at the Promoters of Estrogen-Regulated Genes and Is Not Altered Due to HER-2 OverexpressionCancer Research, 2006
- Structure of caveolaeBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2005
- Survival versus apoptotic 17β‐estradiol effect: Role of ERα and ERβ activated non‐genomic signalingJournal of Cellular Physiology, 2004
- Distinct Nongenomic Signal Transduction Pathways Controlled by 17β-Estradiol Regulate DNA Synthesis and Cyclin D1Gene Transcription in HepG2 CellsMolecular Biology of the Cell, 2002